复杂干预报告不完整:呼吁期刊编辑审查投稿指南
该评论指出干预研究报告不足长期存在,基于对2015-2020年发表的51项随机对照试验的系统综述证据,发现报告不完整仍普遍且清单未用于描述所有干预成分;2022年评估33种期刊投稿指南,仅1种鼓励对所有干预成分使用报告清单,其余32种经联系被要求更新指南。
要点
- 51项随机对照试验的系统综述显示干预报告不完整仍普遍。
- 2022年评估33种期刊投稿指南,仅1种鼓励对所有干预成分使用报告清单。
- 作者联系其余32种期刊编辑要求更新投稿指南,并呼吁所有领域期刊紧急审查指南。
核心结论
- 干预报告不完整仍是普遍问题,清单未被用于描述所有干预成分。
- 2022年评估的33种期刊投稿指南中仅1种鼓励对所有干预成分使用报告清单。
- 作者呼吁所有领域期刊紧急审查投稿指南,通过集体行动建立适用的证据基础。
研究设计与样本
- 评论文章,基于近期对2015-2020年发表的51项随机对照试验的系统综述证据。
- 2022年评估33种期刊的投稿指南,这些期刊发表了上述综述纳入的文章。
主要发现
- 系统综述显示干预报告不完整仍广泛存在,清单未被用于描述所有干预成分。
- 2022年评估的33种期刊中仅1种投稿指南鼓励对所有干预成分使用报告清单。
- 作者联系其余32种期刊编辑,要求更新投稿指南以回应。
临床怎么用
- 作者鼓励所有领域期刊紧急审查投稿指南。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reporting of intervention research has been inadequate for many years. The development and promotion of freely available checklists aims to address this problem by providing researchers with a list of items that require reporting to enable study interpretation and replication. In this commentary, we present evidence from a recent systematic review of 51 randomised controlled trials published 2015-2020 that inadequate intervention reporting remains a widespread issue and that checklists are not being used to describe all intervention components. In 2022, we assessed the submission guidelines of 33 journals that published articles included in our review and found that just one at the time encouraged the use of reporting checklists for all intervention components. To drive progress, we contacted the editors of the other 32 journals and requested that they update their submission guidelines in response. We conclude by highlighting the waste associated with current practices and encourage journals from all fields to urgently review their submission guidelines. Only through collective action can we build an evidence base that is fit for purpose.
引用
- Ryan M, Hoffmann T, Hofmann R, et al. Incomplete reporting of complex interventions: a call to action for journal editors to review their submission guidelines. Trials. 2023. PMID: 36945048. doi:10.1186/s13063-023-07215-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。